Evidence map›Paper›PMID 32850695›Full record

ArticleFrontiers in bioengineering and biotechnology2020

Pan-Cancer Classification Based on Self-Normalizing Neural Networks and Feature Selection.

Junyi Li, Qingzhe Xu, Mingxiao Wu, Tao Huang, Yadong Wang

Abstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Harnessing interpretable deep learning to predict resistance inFrontiers in cellular and infection microbiology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Identification of mClinical epigenetics · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Junyi LiDepartment of Computer Science and Technology, Harbin Institute of Technology, Shenzhen, China.
Qingzhe XuDepartment of Computer Science and Technology, Harbin Institute of Technology, Shenzhen, China.
Mingxiao WuDepartment of Computer Science and Technology, Harbin Institute of Technology, Shenzhen, China.
Tao HuangShanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
Yadong WangDepartment of Computer Science and Technology, Harbin Institute of Technology, Shenzhen, China.

Funding

Ethanol and glutamatergic transmission in the dorsal striatumR01AA021505 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WANG, JUN · 2012 to 2016
$1.4M
NIAAA NIH HHS R01 AA021505
6 · The paper itself

Abstract

Cancer is a one of the severest diseases and cancer classification plays an important role in cancer diagnosis and treatment. Some different cancers even have similar molecular features such as DNA copy number variant. Pan-cancer classification is still non-trivial at molecular level. Herein, we propose a computational method to classify cancer types by using the self-normalizing neural network (SNN) for analyzing pan-cancer copy number variation data. Since the dimension of the copy number variation features is high, the Monte Carlo feature selection method was used to rank these features. Then a classifier was built by SNN and feature selection method to select features. Three thousand six hundred ninety-four features were chosen for the prediction model, which yields the accuracy value is 0.798 and macro F1 is 0.789. We compared our model to random forest method. Results show the accuracy and macro F1 obtained by our classifier are higher than those obtained by random forest classifier, indicating the good predictive power of our method in distinguishing four different cancer types. This method is also extendable to pan-cancer classification for other molecular features.

Indexed as

cancer classificationcopy number variationfeature selectionpan-cancerself-normalizing neural network

Identifiers

PMID32850695
PMCPMC7417299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.